NID2 and metabolic dysfunction-associated steatotic liver disease: To better understand the cell-specific effects of NID2 overexpression in NAFLD and atherosclerosis, future investigations with NID2-AAV with cell-specific promoter (hepatocytes/vascular cells) are required.